JESSICA SCOTT: Open Payments
NPI 1447990288 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$645 in 18 payments from 12 companies in 2025. Trend: 2023 $1,144 · 2024 $811 · 2025 $645
Food & beverage: $645
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 6 | $159 |
| Janssen Biotech, Inc. | 1 | $136 |
| Astellas Pharma US Inc | 1 | $103 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $34 |
| KYOWA KIRIN, INC. | 1 | $26 |
| Incyte Corporation | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| TerSera Therapeutics LLC | 1 | $24 |
| Celgene Corporation | 1 | $24 |
Products named: INGREZZA, RYBREVANT, Vyloy, CAPLYTA, KISQALI, POTELIGEO, MONJUVI, OJJAARA.
Industry payments across TN — which companies pay providers there.
